New Research on Global Deep Brain Stimulation Devices Market for Parkinson's Disease to 2019

Submitted by: Submitted by

Views: 82

Words: 524

Pages: 3

Category: Business and Industry

Date Submitted: 11/24/2014 05:00 AM

Report This Essay

ResearchMoz.us include new market research report " Deep Brain Stimulation Devices Market for Parkinson's Disease 2013 - 2019: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

A rise in the world’s aging population, increase in the number of patients living with Parkinson’s disease and growing awareness about neurological movement disorders among patients have triggered the growth of deep brain stimulation devices market. Globally, neurological disorders are the main causes of mortality; these account for approximately 12% of total number of deaths.

View Full Report with TOC at: http://www.researchmoz.us/cloud-application-marketplace-2014-2019-report.html

Of these, cerebrovascular diseases are responsible for 85% of deaths. Parkinson’s disease is the most common neurodegenerative movement disorder after Alzheimer’s. Symptoms associated with this disease include tremors, slowness of movement, muscle stiffness and trouble with balance.

Drug therapy is the most effective treatment option available to control Parkinson’s disease in the initial stages; however, a large number of medicines are required to control the disease during the advanced stages. In late stage of the disease, deep brain stimulation (DBS) surgical treatment is used to control the involuntary symptoms. DBS is an effective, clinically proven and the U.S. FDA approved advanced surgical option to treat mild to severe Parkinson’s disease. The market for DBS devices is expected to grow at a healthy rate during the forecast period of 2013 to 2019. However, high cost involvement in the surgical procedure may hamper the growth of the market. A growing burden of Parkinson’s disease on the healthcare system coupled with uncertain economic conditions in the U.S. and Europe has forced Original Equipment Manufacturers (OEMs) to develop cost-effective devices for the treatment of neurological movement disorders.

The research report on DBS...